Tianjin Pharmaceutical Da Ren Tang Group Corp Ltd
SSE:600329

Watchlist Manager
Tianjin Pharmaceutical Da Ren Tang Group Corp Ltd Logo
Tianjin Pharmaceutical Da Ren Tang Group Corp Ltd
SSE:600329
Watchlist
Price: 31.6 CNY -0.54% Market Closed
Market Cap: 24.3B CNY
Have any thoughts about
Tianjin Pharmaceutical Da Ren Tang Group Corp Ltd?
Write Note

Tianjin Pharmaceutical Da Ren Tang Group Corp Ltd
Cash Paid for Dividends

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Tianjin Pharmaceutical Da Ren Tang Group Corp Ltd
Cash Paid for Dividends Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Cash Paid for Dividends CAGR 3Y CAGR 5Y CAGR 10Y
Tianjin Pharmaceutical Da Ren Tang Group Corp Ltd
SSE:600329
Cash Paid for Dividends
-ÂĄ989.6m
CAGR 3-Years
-62%
CAGR 5-Years
-41%
CAGR 10-Years
-15%
H
Hansoh Pharmaceutical Group Company Ltd
HKEX:3692
Cash Paid for Dividends
-ÂĄ652.1m
CAGR 3-Years
46%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Zhangzhou Pientzehuang Pharmaceutical Co Ltd
SSE:600436
Cash Paid for Dividends
-ÂĄ2.2B
CAGR 3-Years
-56%
CAGR 5-Years
-41%
CAGR 10-Years
-27%
Jiangsu Hengrui Pharmaceuticals Co Ltd
SSE:600276
Cash Paid for Dividends
-ÂĄ1.3B
CAGR 3-Years
-6%
CAGR 5-Years
-6%
CAGR 10-Years
-26%
Yunnan Baiyao Group Co Ltd
SZSE:000538
Cash Paid for Dividends
-ÂĄ3.8B
CAGR 3-Years
9%
CAGR 5-Years
-20%
CAGR 10-Years
-26%
S
Sichuan Biokin Pharmaceutical Co Ltd
SSE:688506
Cash Paid for Dividends
-ÂĄ18.8m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

Tianjin Pharmaceutical Da Ren Tang Group Corp Ltd
Glance View

Market Cap
24.3B CNY
Industry
Pharmaceuticals

Tianjin Pharmaceutical Da Ren Tang Group Corp Ltd, rooted in the rich tapestry of traditional Chinese medicine, has carved out a substantial presence in the pharmaceutical industry. Established in a region known for its deep cultural heritage in holistic healing, the company seamlessly weaves ancient practices with modern scientific advancements. At the core of its operations, Da Ren Tang specializes in the research, development, production, and distribution of traditional Chinese medicine and pharmaceuticals. Beyond just leveraging ancient recipes, the company invests significantly in cutting-edge research to validate and enhance the efficacy of its formulations, gaining trust not only domestically but also in international markets. This blending of tradition and innovation enables Da Ren Tang to capture a diverse customer base, ranging from individuals seeking natural remedies to medical institutions incorporating holistic approaches into patient care. The economic engine of Da Ren Tang powers through a multi-faceted monetization strategy. It manufactures a broad portfolio of pharmaceutical products, including patented Chinese medicines and active pharmaceutical ingredients (APIs), which are distributed through a well-established network of pharmacies and healthcare providers. Additionally, the company has embraced the digital era by exploring e-commerce platforms, thereby expanding its reach and accessibility to tech-savvy consumers globally. By maintaining stringent quality controls and adopting sustainable practices in its production processes, Da Ren Tang not only enhances its reputation but also adheres to evolving regulatory standards worldwide. Such strategic positioning allows the company to capitalize on the growing global interest in traditional medicines, contributing significantly to its revenue streams and reinforcing its status as a prominent player in the pharmaceutical landscape.

Intrinsic Value
39.26 CNY
Undervaluation 20%
Intrinsic Value
Price

See Also

What is Tianjin Pharmaceutical Da Ren Tang Group Corp Ltd's Cash Paid for Dividends?
Cash Paid for Dividends
-989.6m CNY

Based on the financial report for Sep 30, 2024, Tianjin Pharmaceutical Da Ren Tang Group Corp Ltd's Cash Paid for Dividends amounts to -989.6m CNY.

What is Tianjin Pharmaceutical Da Ren Tang Group Corp Ltd's Cash Paid for Dividends growth rate?
Cash Paid for Dividends CAGR 10Y
-15%

Over the last year, the Cash Paid for Dividends growth was -13%. The average annual Cash Paid for Dividends growth rates for Tianjin Pharmaceutical Da Ren Tang Group Corp Ltd have been -62% over the past three years , -41% over the past five years , and -15% over the past ten years .

Back to Top